US Stock MarketDetailed Quotes

InMed Pharmaceuticals (INM)

Watchlist
  • 1.070
  • -0.080-6.96%
Close Jan 22 16:00 ET
3.00MMarket Cap-0.18P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals (INM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
Total revenue
-11.43%1.12M
7.50%4.94M
1.69%1.3M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
Operating revenue
-11.43%1.12M
7.50%4.94M
1.69%1.3M
7.59%1.26M
-10.36%1.11M
40.23%1.26M
11.18%4.6M
-44.48%1.28M
13.41%1.17M
163.99%1.24M
Cost of revenue
-7.04%716.96K
-7.46%3.24M
-10.89%728.06K
22.96%1.09M
-28.96%650.81K
-12.42%771.23K
27.97%3.5M
10.30%817K
4.96%883.14K
170.53%916.06K
Gross profit
-18.29%403.16K
55.02%1.71M
23.73%576.65K
-39.33%175.63K
42.19%460.89K
2,222.82%493.41K
-21.53%1.1M
-70.32%466.07K
50.36%289.46K
147.13%324.14K
Operating expense
-3.60%2.17M
4.21%9.62M
-2.27%2.42M
9.84%2.29M
31.45%2.67M
-15.04%2.25M
-5.59%9.24M
18.62%2.48M
-10.94%2.09M
-14.22%2.03M
Selling and administrative expenses
2.62%1.53M
13.10%6.56M
27.92%2.25M
-3.28%1.33M
13.90%1.55M
14.96%1.49M
-0.84%5.8M
24.98%1.76M
-2.73%1.37M
-6.89%1.36M
-General and administrative expense
2.62%1.53M
13.10%6.56M
27.92%2.25M
-3.28%1.33M
13.90%1.55M
14.96%1.49M
-0.84%5.8M
24.98%1.76M
-2.73%1.37M
-6.89%1.36M
Research and development costs
-16.93%581.61K
-11.30%2.85M
-82.89%112.72K
38.51%909.65K
73.89%1.06M
-45.81%700.15K
-13.79%3.22M
5.63%658.87K
-25.22%656.76K
-28.37%609.79K
Depreciation amortization depletion
-2.52%53.2K
-3.08%212.84K
-3.68%52.75K
-4.49%52.31K
-3.68%53.2K
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
-Depreciation and amortization
-2.52%53.2K
-3.08%212.84K
-3.68%52.75K
-4.49%52.31K
-3.68%53.2K
-0.46%54.58K
8.58%219.6K
2.44%54.77K
8.05%54.77K
12.61%55.23K
Operating profit
-0.54%-1.76M
2.66%-7.92M
8.31%-1.84M
-17.77%-2.12M
-29.41%-2.21M
33.16%-1.75M
2.92%-8.13M
-289.14%-2.01M
16.43%-1.8M
23.69%-1.7M
Net non-operating interest income expense
64.23%93.77K
-140.85%-215.67K
-69.43%31.69K
-86.36%16.57K
-292.50%-321.01K
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
Non-operating interest income
64.23%93.77K
-70.47%155.88K
-50.13%51.69K
-86.36%16.57K
-81.69%30.54K
-58.03%57.09K
7.20%527.9K
-30.24%103.64K
-21.89%121.46K
44.01%166.76K
Non-operating interest expense
----
--371.55K
--20K
--0
--351.55K
----
--0
--0
--0
--0
Other net income (expense)
-395.15%-56.99K
54.02%-28.47K
187.83%22.14K
53.97%-22.17K
-179.73%-47.75K
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
Gain on sale of security
-395.15%-56.99K
54.02%-28.47K
187.83%22.14K
53.97%-22.17K
-179.73%-47.75K
139.85%19.31K
-28.53%-61.92K
-181.01%-25.2K
-1,662.02%-48.16K
195.97%59.9K
Income before tax
-2.92%-1.73M
-6.44%-8.16M
7.37%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.35%-7.67M
-473.57%-1.93M
13.70%-1.72M
29.55%-1.48M
Income tax
0
0
0
0
0
-45.80%7.1K
294.44%7.1K
0
0
Net income
-2.92%-1.73M
-6.34%-8.16M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
Net income continuous Operations
-2.92%-1.73M
-6.34%-8.16M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
Minority interest income
Net income attributable to the parent company
-2.92%-1.73M
-6.34%-8.16M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-2.92%-1.73M
-6.34%-8.16M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
Basic earnings per share
83.76%-0.44
58.49%-8.36
75.60%-0.8932
45.81%-1.94
1.89%-3.64
82.22%-2.71
69.02%-20.14
-165.36%-3.66
70.17%-3.58
79.62%-3.71
Diluted earnings per share
83.76%-0.44
58.49%-8.36
75.60%-0.8932
45.81%-1.94
1.89%-3.64
82.22%-2.71
69.02%-20.14
-165.36%-3.66
70.17%-3.58
79.62%-3.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023
Total revenue -11.43%1.12M7.50%4.94M1.69%1.3M7.59%1.26M-10.36%1.11M40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M
Operating revenue -11.43%1.12M7.50%4.94M1.69%1.3M7.59%1.26M-10.36%1.11M40.23%1.26M11.18%4.6M-44.48%1.28M13.41%1.17M163.99%1.24M
Cost of revenue -7.04%716.96K-7.46%3.24M-10.89%728.06K22.96%1.09M-28.96%650.81K-12.42%771.23K27.97%3.5M10.30%817K4.96%883.14K170.53%916.06K
Gross profit -18.29%403.16K55.02%1.71M23.73%576.65K-39.33%175.63K42.19%460.89K2,222.82%493.41K-21.53%1.1M-70.32%466.07K50.36%289.46K147.13%324.14K
Operating expense -3.60%2.17M4.21%9.62M-2.27%2.42M9.84%2.29M31.45%2.67M-15.04%2.25M-5.59%9.24M18.62%2.48M-10.94%2.09M-14.22%2.03M
Selling and administrative expenses 2.62%1.53M13.10%6.56M27.92%2.25M-3.28%1.33M13.90%1.55M14.96%1.49M-0.84%5.8M24.98%1.76M-2.73%1.37M-6.89%1.36M
-General and administrative expense 2.62%1.53M13.10%6.56M27.92%2.25M-3.28%1.33M13.90%1.55M14.96%1.49M-0.84%5.8M24.98%1.76M-2.73%1.37M-6.89%1.36M
Research and development costs -16.93%581.61K-11.30%2.85M-82.89%112.72K38.51%909.65K73.89%1.06M-45.81%700.15K-13.79%3.22M5.63%658.87K-25.22%656.76K-28.37%609.79K
Depreciation amortization depletion -2.52%53.2K-3.08%212.84K-3.68%52.75K-4.49%52.31K-3.68%53.2K-0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K
-Depreciation and amortization -2.52%53.2K-3.08%212.84K-3.68%52.75K-4.49%52.31K-3.68%53.2K-0.46%54.58K8.58%219.6K2.44%54.77K8.05%54.77K12.61%55.23K
Operating profit -0.54%-1.76M2.66%-7.92M8.31%-1.84M-17.77%-2.12M-29.41%-2.21M33.16%-1.75M2.92%-8.13M-289.14%-2.01M16.43%-1.8M23.69%-1.7M
Net non-operating interest income expense 64.23%93.77K-140.85%-215.67K-69.43%31.69K-86.36%16.57K-292.50%-321.01K-58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K
Non-operating interest income 64.23%93.77K-70.47%155.88K-50.13%51.69K-86.36%16.57K-81.69%30.54K-58.03%57.09K7.20%527.9K-30.24%103.64K-21.89%121.46K44.01%166.76K
Non-operating interest expense ------371.55K--20K--0--351.55K------0--0--0--0
Other net income (expense) -395.15%-56.99K54.02%-28.47K187.83%22.14K53.97%-22.17K-179.73%-47.75K139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K
Gain on sale of security -395.15%-56.99K54.02%-28.47K187.83%22.14K53.97%-22.17K-179.73%-47.75K139.85%19.31K-28.53%-61.92K-181.01%-25.2K-1,662.02%-48.16K195.97%59.9K
Income before tax -2.92%-1.73M-6.44%-8.16M7.37%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.35%-7.67M-473.57%-1.93M13.70%-1.72M29.55%-1.48M
Income tax 00000-45.80%7.1K294.44%7.1K00
Net income -2.92%-1.73M-6.34%-8.16M7.71%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M
Net income continuous Operations -2.92%-1.73M-6.34%-8.16M7.71%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M
Minority interest income
Net income attributable to the parent company -2.92%-1.73M-6.34%-8.16M7.71%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -2.92%-1.73M-6.34%-8.16M7.71%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M
Basic earnings per share 83.76%-0.4458.49%-8.3675.60%-0.893245.81%-1.941.89%-3.6482.22%-2.7169.02%-20.14-165.36%-3.6670.17%-3.5879.62%-3.71
Diluted earnings per share 83.76%-0.4458.49%-8.3675.60%-0.893245.81%-1.941.89%-3.6482.22%-2.7169.02%-20.14-165.36%-3.6670.17%-3.5879.62%-3.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -